Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega Interferon +/- Ribavirin in Hepatitis C
NCT00097045Phase 2Completed
- Sponsor
- Intarcia Therapeutics
- Start
- Nov 2004
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of human interferon omega-1 in hepatitis C (HCV), sponsored by Intarcia Therapeutics. Started Nov 2004; status: completed.
02
Drugs
human interferon omega-1
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00097045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00097045.